1 Product identity
Ingredient risk
2 ingredients to use with caution
G-150 Benfotiamine 150 mg
BrandBenfoComplete.com→Vitamin Capsule 6 ingredients 2 caution DSLD #272290Net contents: 120 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2022-08-23
2 Ingredients (6)
IngredientGroupSafety
BenfotiamineBenfotiamine—
GelatinGelatin—
Microcrystalline CelluloseCellulose—
WaterWater—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Thiamin — Wernicke encephalopathy: classic triad (confusion, ophthalmoplegia, ataxia) is present in only 16% of cases — any ONE element in an at-risk patie…
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Thiamin — Use with Caution
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID272290
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2022-08-23
6 More from BenfoComplete.com
View BenfoComplete.com Safety Scorecard → 2 products
Multi-B Benfotiamine 150 mg7 Cite this page
Vancouver
Pkhakadze G. G-150 Benfotiamine 150 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 24]. Available from: https://supplement.ge/products/dsld-272290/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG